Search results for "Highlights"
Use of drugs, nondrug treatments for functional bowel disorders analyzed
One study found that nonpharmacologic interventions are underused in ambulatory care visits for functional bowel disorders, while another found that patients with irritable bowel disease and their insurers have financial incentives to favor differing treatments.
https://gastroenterology.acponline.org/archives/2020/10/23/1.htm
23 Oct 2020
Studies examine effects of EHR nudges, physician uptake on CRC screening
Active choice interventions in an EHR prompted an increase in ordering of cancer screenings but not patient follow-through, while physicians who themselves underwent colorectal cancer (CRC) screening had more patients do so as well.
https://gastroenterology.acponline.org/archives/2019/11/22/2.htm
22 Nov 2019
Spotlight on esophageal adenocarcinoma
High-dose proton-pump inhibitors and aspirin appeared effective for chemoprevention in patients with Barrett's esophagus in one study, while another study found a positive association between human papillomavirus status and survival in patients with Barrett's high-grade dysplasia and esophageal adenocarcinoma.
https://gastroenterology.acponline.org/archives/2018/08/24/5.htm
24 Aug 2018
Spotlight on ulcerative colitis
In the past month, the American Gastroenterological Association published new recommendations, a meta-analysis compared first- and second-line treatments, and a study found a recent decrease in colorectal cancer incidence in patients with ulcerative colitis.
https://gastroenterology.acponline.org/archives/2020/01/24/5.htm
24 Jan 2020
Sodium polystyrene sulfonate associated with GI events requiring hospitalization in elderly
An accompanying editorial said that based on the risk of gastrointestinal (GI) events found in this retrospective study, sodium polystyrene sulfonate should not be used to reduce serum potassium levels.
https://gastroenterology.acponline.org/archives/2019/06/28/2.htm
28 Jun 2019
Anti-TNF therapy did not reduce IBD hospitalizations or intestinal resections in Ontario
Infliximab may have been used inappropriately in Crohn's disease and underused in ulcerative colitis, according to the authors of an analysis of hospitalizations, intestinal resections, and drug costs related to inflammatory bowel disease (IBD).
https://gastroenterology.acponline.org/archives/2019/06/28/3.htm
28 Jun 2019
Hepatitis A infections nearly triple, with some states seeing 5-fold increase, CDC says
The increase primarily occurred among people who reported drug use or homelessness.
https://gastroenterology.acponline.org/archives/2019/05/24/2.htm
24 May 2019
PPI use associated with more severe illness from COVID-19
A Korean cohort study did not find any association between use of proton-pump inhibitors (PPIs) and risk of infection with SARS-CoV-2, but current use was associated with higher risk of a composite endpoint that included ICU admission, mechanical ventilation, or death from COVID-19.
https://gastroenterology.acponline.org/archives/2020/08/28/1.htm
28 Aug 2020
ACG lowers suggested age for colorectal cancer screening in updated guidelines
The American College of Gastroenterology (ACG) continues to recommend colorectal cancer screening in average-risk adults ages 50 to 75 years but now also suggests it in those ages 45 to 49 years.
https://gastroenterology.acponline.org/archives/2021/03/26/1.htm
26 Mar 2021
Weight loss interventions may improve biomarkers of liver disease in NAFLD
In a meta-analysis of 22 studies in patients with nonalcoholic fatty liver disease (NAFLD), weight loss interventions were associated with improvements in alanine aminotransferase level, liver steatosis, histologic NAFLD activity score, and nonalcoholic steatohepatitis.
https://gastroenterology.acponline.org/archives/2019/07/26/3.htm
26 Jul 2019